Market News

In the news release, Trulieve Announces Grand Opening of its Affiliate's (Chamounix Ventures, LLC) Philadelphia Dispensary, issued 07-Jan-2022 by Trulieve Cannabis Corp. over PR Newswire, we are advised by the company that the headline and first paragraph, first sentence, should read " Affiliate's (Harvest of Southeast, PA, LLC) Philadelphia Dispensary" and "through its affiliate, Harvest of Southeast, PA, LLC" rather than "Affiliate's (Chamounix Ventures, LLC) Philadelphia Dispensary" and "through its affiliate, Chamounix Ventures, LLC" as originally issued inadvertently. The complete, corrected release follows:

Trulieve Announces Grand Opening of its Affiliate's (Harvest of Southeast, PA, LLC) Philadelphia Dispensary

Medical marijuana dispensary opens Saturday, January 8

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new Trulieve-branded medical marijuana dispensary through its affiliate, Harvest of Southeast, PA, LLC. The dispensary at 1222 Arch St. is in the Center City section of Philadelphia . This location becomes the Company's 160th owned, operated or affiliated dispensary nationwide.

Located in the heart of Philadelphia , between City Hall and Reading Terminal Market, the dispensary will be open Monday – Saturday from 9am 8pm and on Sunday from 10am 6pm . Patients can choose from Trulieve's selection of premium whole flower products, including TruFlower and Cultivar Collection, as well as a wide range of vapes, tinctures, topicals and ingestibles.

"We are proud to begin the New Year by demonstrating our ongoing commitment to serving Pennsylvania's patient community through high quality and reliable medical marijuana products," said Kim Rivers , CEO of Trulieve. "We look forward to welcoming patients and strengthening community connections in this cornerstone market."

Additional Trulieve-affiliated dispensaries in Pennsylvania are located in Camp Hill , Cranberry Township , Devon , Harrisburg , Johnstown , King of Prussia , Pittsburgh , Reading , Scranton , Washington , Whitehall , York and Zelienople .

To find a location or to learn how to become a registered patient, visit Trulieve.com , follow us on Instagram at trulieve_pa or connect with Trulieve PA on Facebook.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Director of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Rob Kremer , Executive Director of Corporate Communications
+1 (404) 218-3077
Robert.Kremer@Trulieve.com

MATTIO Communications
Trulieve@Mattio.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-grand-opening-of-its-affiliates-chamounix-ventures-llc-philadelphia-dispensary-301456254.html

SOURCE Trulieve Cannabis Corp.

News Provided by PR Newswire via QuoteMedia

TCNNF,TRUL:CNX
Little Green Pharma logo

LGP Signs Exclusive Distribution Agreement With Pharmaserve Hellas

Greece added to rapidly expanding EU distribution portfolio. LGP now has distribution agreements in 5 EU territories including France, Denmark, Germany, Poland and Greece.

Little Green Pharma Ltd (ASX: LGP, “LGP” or the “Company”) is pleased to announce its entry into an exclusive agreement with PharmaServe Hellas SMSACI (“PharmaServe”) for the distribution of LGP-branded oil medicines and cannabis flower in Greece (“Agreement”).

Keep reading... Show less
Numinus Wellness Inc. Reports Q1 2022 Results

Numinus Wellness Inc. Reports Q1 2022 Results

  • Ended quarter with strong cash position of $53.9 million
  • Revenues grew 245% year-over-year to $0.8 million for the quarter
  • Generated gross profit of $50,965 during the quarter, representing a 6.5% gross margin
  • Well-positioned to offer psychedelic-assisted psychotherapy services through Canada's newly expanded Special Access Program
  • Clinical trial application made to Health Canada to begin Phase 1 study for proprietary psilocybe extract
  • MAPS-sponsored MDMA-Assisted Therapy for PTSD study to begin shortly; approvals received from Health Canada and the Institutional Review Board

All financial results are reported in Canadian dollars unless otherwise stated.

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTC: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its fiscal first quarter results for the three months ended November 30, 2021 .

Keep reading... Show less
AYURCANN HOLDINGS CORP. UPDATE FOR 2022

AYURCANN HOLDINGS CORP. UPDATE FOR 2022

Ayurcann Holdings Corp. ( CSE: AYUR OTCQB: CDCLF FSE: 3ZQ0 ) (the " Company "), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 products in the medical and recreational market, is pleased to provide an update to its exponential growth throughout Canada.

Ayurcann Market segments

Keep reading... Show less

Curaleaf Opens Two New Pennsylvania Dispensaries

New locations in Greensburg and Wayne expand the Company's retail presence to 14 locations in one of the country' s largest medical markets

Curaleaf Holdings, Inc . (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced plans to open two new dispensaries in Pennsylvania . Curaleaf's latest locations in Greensburg and Wayne will increase the Company's retail footprint to 14 dispensaries statewide and 125 across the country. Two additional locations, Curaleaf Erie (7891 Peach St.) and Curaleaf State College (1248 S Atherton St.), are expected to open by the end of February, pending regulatory approval.

Keep reading... Show less
Tinley's Long Beach Facility to Produce 'Green Monké' Sodas on Can Line; Tinley's Closes First Tranche of Non-Brokered Private Placement

Tinley's Long Beach Facility to Produce 'Green Monké' Sodas on Can Line; Tinley's Closes First Tranche of Non-Brokered Private Placement

The Tinley Beverage Company Inc. (CSE:TNY; OTC:TNYBF) ("Tinley's" or the "Company") is pleased to announce that international cannabis beverage brand ‘Green Monké' is scheduled to begin can line production of five planned flavours at Tinley's Long Beach Facility in Q1 2022, with production of full-batches expected to repeat near-monthly.

‘Green Monké' Happy Sodas are cannabis-infused sparkling drinks in tropical flavours, formulated with a fast-release microencapsulation emulsion, and only 25 calories per can. ‘Green Monké' THC-infused beverages are currently available in the State of California, and Green Monké THC-infused beverages launched in Canada in October 2021. ‘Green Monké' is owned by St. Peter's Spirits. The Tinley Beverage Company Inc. (CSE:TNY; OTC:TNYBF) ("Tinley's" or the "Company") is pleased to announce that international cannabis beverage brand ‘Green Monké' is scheduled to begin can line production of five planned flavours at Tinley's Long Beach Facility in Q1 2022, with production of full-batches expected to repeat near-monthly.

Keep reading... Show less

CURALEAF COMPLETES ACQUISITION OF BLOOM DISPENSARIES

- Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the completion of its previously announced acquisition of Bloom Dispensaries ("Bloom"), a vertically integrated, single state cannabis operator in Arizona (the "Transaction"). With the close of the Transaction, Curaleaf's retail footprint has reached 13 dispensaries in Arizona and 121 nationwide.

Boris Jordan , Executive Chairman of Curaleaf, stated, "Bloom is an excellent strategic fit for Curaleaf as it further expands our capacity and retail footprint in Arizona with an attractive set of assets, enabling us to better serve the state's US$1.4 billion -plus annual market opportunity. Adding to these benefits, Bloom will be immediately accretive to our adjusted EBITDA margins. On behalf of the Board of Directors and management team, I am pleased to officially welcome Bloom to the Curaleaf family."

Keep reading... Show less

Latest Press Releases

Related News

×